ORBuys S-44300-00001995 OHA-RFA-5171 Final Form Price Agreement Attachment 2 QEA Review Form~1.pdf

PDF 4 MB Posted

Attached to
Review of Waiver and Hazard Assessment Requests
Solicitation number
S-44300-00001995
Issued by
Marion County, Oregon

About this file

This document is a Quantitative Exposure Assessment (QEA) Review Form related to a contract opportunity with the Oregon Health Authority (OHA). The QEA is submitted by manufacturers or trade associations to support a waiver request per Oregon Administrative Rule (OAR) 333-016-3040(2)(a) to continue selling children's products containing High Priority Chemicals of Concern for Children's Health (HPCCCH) at or above de minimis levels in Oregon. The QEA must identify the brand name and product model (BNPM) of the children's products and provide information on the leachability and bioavailability of HPCCCH to demonstrate that levels are less than or equal to the Practical Quantitation Limit (PQL) established in OAR 333-016-2035(2).

The QEA Review Form requires the contractor to evaluate the adequacy of the product descriptions, exposure scenarios, leachability and bioavailability data, and compliance with OAR requirements. The contractor must also note any BNPMs that are aggregated but are not likely to meet the criteria for aggregation. Upon completion, the QEA Review Form is submitted to OHA along with the QEA.

View the file

Other files

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

A. Manufacturer (or Trade Association) Submitting QEA:

Date Received by OHA:

PUBLIC HEALTH DIVISON

Center for Health Protection

[Section A for OHA use only]

Name:

B. Contractor Information:

Reviewer's Phone:

Firm Name:

Reviewer Name(s):

Reviewer’s Email:

Date Review Completed:

Directions for Contractor for Completion of Review Forms Please review this Quantitative Exposure Assessment (QEA) submitted in support of a Waiver per Oregon Administrative Rule (OAR) 333-016-3040(2)(a). If approved, specified children's products containing High Priority Chemicals of Concern for Children's Health at or above de minimis may continue to be sold in Oregon.

OAR 333-016-3050(5) requires that children's products on which a QEA is conducted be identified per OAR 333-016-3010(3)(a) through (c) at the brand name, product model level (hereafter, BNPM or children's product).

Contractors should cut-and-pasteΣ ƛƴǘƻ ŀƴ ŀǘǘŀŎƘƳŜƴǘΣ information identifying each BNPM in the QEAΦ In the attachment, each BNPM should be give a unique identifier that may subsequently referred to in the Contractor's reviews. This attachment should be sent to OHA along with the completed Review Form(s) for anQEA.

A QEA Review Form is on the next page. Manufacturers are allowed to aggregate responses for substantially similar BNPM per Item 6 in QEA Guidance. Therefore, /ontractors may evaluate such responses in ŀ ǎƛƴƎƭŜ wŜǾƛŜǿ CƻNJƳΦ Contractors should note, in the space at the bottom of the QEA below, those aggregated BNPMs likely to have HPCCCH concentrations that vary more than 10% from concentrations of the same HPCCCH in the group, thus not qualifying for aggregation.

CƛƴŀƭƭȅΣ It///I ŘNJƻLJπŘƻǿƴ ƭƛǎǘǎ ŀNJŜ ŀǘ ǘƘŜ ǘƻLJ ƻŦ the QEA Review Form. In the lists, /ƻƴǘNJŀŎǘƻNJǎ ǎƘƻdzƭŘ ǎŜƭŜŎǘ It///Iǎ ŘƛǎŎdzǎǎŜd in the QEA. Review Forms may be reproduced, as needed, ensure an evaluation of each BNPM and HPCCCH.

Questions? Please contact the Authority’s Toxic-Free Kids Program at toxicfreekids.program@state.or.us.

QEA Review Form - Ver 1.0

Kate Brown, Governor

Attachment 2 - Quantitative Exposure Assessment (QEA) Review Form (per OAR 333-016-3050)

SAMPLE

https://www.oregon.gov/oha/PH/HEALTHYENVIRONMENTS/HEALTHYNEIGHBORHOODS/TOXICSUBSTANCES/Documents/Guidance%20for%20Quantitative%20Exposure%20Assessment%20per%20OAR%20333-016-3050%20ver1.1.pdf https://secure.sos.state.or.us/oard/viewSingleRule.action?ruleVrsnRsn=276970 https://secure.sos.state.or.us/oard/viewSingleRule.action?ruleVrsnRsn=276975 https://secure.sos.state.or.us/oard/viewSingleRule.action?ruleVrsnRsn=276975 https://secure.sos.state.or.us/oard/viewSingleRule.action?ruleVrsnRsn=276974

1. Does the description of the children's product provided adequately identify the product per OAR Adequate Inadequate 333-016-3010(3)? [Please see #3 in QEA Guidance.]

If adequate, what information is needed to change this conclusion?

2. STEP A - Do the exposure scenario(s) provided adequately describe how, if at all, the HPCCCH in the BNPM could reasonably be anticipated to enter a child’s body through a completed exposure pathway because of leachability and bioavailability from the BNPM? [Please see #4 in QEA Guidance.]

• If inadequate, briefly describe below identified deficiencies below.

QEA Review: List Brand name, Product Model (BNPM)

Summary Report for:

QEA Review Form - Ver 1.0 3

Items 1-4 below described in QEA Guidance

3. STEP B - First Option - For each completed exposure pathway stated above, does the information submitted on the leachability and bioavailability of HPCCCH from a product adequately satisfy requirements of OAR 333-016-3050(2)(b)?

Reminder: per OAR 333-016-3050(6), to be approved a QEA for a BNPM must demonstrate that HPCCCCH concentrations measured in the appropriate media be less than or equal to the PQL of the HPCCCH established in OAR 333-016-2035(2) in effect for the biennial notice period for which the QEA is requested. [The Authority will

• If inadequate, briefly describe below identified deficiencies below.

Adequate Inadequate

4. STEP B - Second Option - Per OAR 333-016-3050(2)(c), does the information submitted adequately satisfy requirements of OAR 333-016-3050(2)(c)? Adequate Inadequate

Adequate Inadequatee

• Does the information provided adequately respond to the requirements of 333-016-3050(2)(a)?

provide correct version of OAR 333-016-2035(2) to Contractor.]

• If inadequate, briefly describe below identified deficiencies below.

Check this box if this QEA contains an aggregation of BNPMs not likely to meet criteria for aggregation per #6 of QEA Guidance? If so, please list Unique Identifiers for such BNPMs in the space below:

SAMPLE

Q2: Off
HPCCCH: [HPCCCH]
Name of Entity Submitting MCP:
mm/dd/yyyy:
Q3: Off
Q4: Off
Q1: Off
Additional information needed for #1:
Unique Identifier(s) for BNPM(s):
Check Box1: Off
Unique identifier of BNPMs not likely meeting criteria of QEA #6:
Identified deficiencies for 2:
STEP A:
Item 2 STEP B 1st Option - Identified Deficiencies:
Item 2 STEP B, 2nd Option - Identified Deficiencies:
mm/dd/yyyyy:
Name of Firm Contracting with OHA:
Reviewer's Email:
Reviewer Name(s):
Reviewer's Phone:

File details come from the government source that posted it. Updated .